4.6 Editorial Material

Post-operative radioactive iodine administration in patients with low-risk thyroid cancer

Journal

NATURE REVIEWS ENDOCRINOLOGY
Volume 18, Issue 10, Pages 585-586

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41574-022-00709-z

Keywords

-

Ask authors/readers for more resources

RAI treatment is used in thyroid cancer patients for disease treatment and removal of normal thyroid remnants. Routine post-operative administration of RAI is no longer recommended in low risk thyroid cancer patients.
Radioactive iodine (RAI) treatment is used in patients with thyroid cancer to treat disease and to eradicate normal thyroid remnants. Routine post-operative administration of RAI is no longer indicated in patients with low risk thyroid cancer and might instead be used selectively in patients with a post-operative high serum level of thyroglobulin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available